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A B S T R A C T
Papillary cystadenoma of the epididymis (PCE) is the second most common benign neoplasm of the epididymis
[1]. It is very uncommon and has never been reported in a prepubertal male. It may occur sporadically, but more
often occurs in association with von Hippel- Lindau (VHL) disease [2]. There have been over 60 reports of
patients with such tumors, with the youngest patient being 16 years old.
We present the case of a 12- year old male with a history of stage IV neuroblastoma. He presented with a left
paratesticular mass that was discovered on routine follow up physical exam with his pediatric oncologist. He was
asymptomatic at the time of presentation with no signs or symptoms of hypoandrogenism. A computed tomo-
graphy scan of the abdomen and pelvis was negative for lymphadenopathy and additional disease sites. Given
the patient's history of stage IV neuroblastoma, there was suspicion of yolk sac tumor or metastases; he un-
derwent an open radical left orchiectomy. Frozen section was consistent with yolk sac tumor, however ﬁnal
pathology revealed normal testicle with PCE.
To date, this patient is the youngest reported patient with this diagnosis; furthermore papillary cystadenoma
of the epididymis has never been reported in a patient with neuroblastoma.
1. Introduction
Testicular and paratesticular tumors are rare in prepubertal males,
and represent 1–2% of the solid tumors in the pediatric population.
Benign neoplasms (the most common of which are leiomyoma, ﬁbroma,
lipoma, hemangioma) should be distinguished from malignant tumors
including leiomyosarcoma, ﬁbrosarcoma, liposarcoma, rhabdomyo-
sarcoma and metastatic disease as it may be possible to spare the testis
during resection of the former. Only a minority of paratesticular tumors
arise from the epididymis and the majority of these are benign me-
senchymal neoplasms (i.e. adenomatoid tumor) [2]. Papillary cystade-
noma(PCE), the second most common epididymal tumor, is an ex-
tremely rare, benign tumor of epithelial origin ﬁrst described in 1956 in
a 21-year-old male [1]. To date, fewer than 80 cases have been re-
ported, two-thirds of these occurring in association with Von Hippel
Lindau (VHL) syndrome.
PCE develops in the eﬀerent ductules of the epididymis and
typically presents as a painless, slowly growing, scrotal mass in a post-
pubertal male. Genetically it is associated with an allelic loss of the VHL
gene [3]. Histologically, papillary cystadenoma resembles renal cell
carcinoma and requires immunohistochemical distinction. Of the re-
ported cases, about 40% were bilateral and 75% of these bilateral cases
occurred in conjunction with VHL. Treatment of PCE consists of testicle
sparing surgical excision with longitudinal surveillance due to a report
of recurrence and two reports of transformation to cystadenocarcinoma
[2]. To date, there have been no reports of cases of epididymal papillary
cystadenoma in a prepubertal male.
2. Case report
A 12-year-old male with a history of stage IV high risk neuro-
blastoma, diagnosed eleven years prior to his current presentation and
status post left adrenalectomy, right hepatectomy, chemotherapy, total
body irradiation, and stem cell transplant, presented to his
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endocrinologist for routine survivorship follow-up. On physical exam, a
nontender left paratesticular mass was palpated posterior to the testicle.
There were no overlying skin changes to the scrotum and there was no
palpable inguinal lymphadenopathy. His vital signs were otherwise
stables and routine laboratory investigations including AFP, bHCG,
LDH were within normal limits. The right testicle was normal with no
masses palpated. A scrotal ultrasound showed a complex, pre-
dominantly solid appearing lesion measuring 1.3 × 1.2 cm in size be-
tween the left testicle and epididymis that was heterogeneous and. A CT
chest abdomen and pelvis was done at the same time and showed no
evidence of tumor recurrence, lymphadenopathy or other foci of dis-
ease.
On physical exam, he had no evidence of inguinal lymphadeno-
pathy. While neuroblastoma relapse was considered unlikely (although
possible), a secondary malignancy was thought likely given his previous
history of chemo and radiotherapy. The patient underwent an open
exploration of his spermatic cord and testis via an inguinal approach. A
well circumscribed mass was identiﬁed adjacent to the testis and in-
separable from the epididymis. Frozen section was consistent with
possible yolk sac tumor. For that reason, he underwent a left open ra-
dical orchiectomy via an inguinal approach; a lymph node dissection
was not performed. He did well postoperatively and was discharged
home on postoperative day 1. Final pathology revealed papillary cy-
stadenoma of the epididymis. On follow up in the clinic, he was doing
well with no complaints. Follow up brain MRI and CT of chest/ab-
domen/pelvis to rule out VHL were without signiﬁcant ﬁndings.
3. Pathology
Gross pathology revealed a cystic mass inﬁltrating into the epidi-
dymis with a normal testicle just above the mass (Fig. 1). Hematoxylin
and eosin (H&E) stain shows the epididymal duct with the papillary
neoplasm and papillary projections into the cysts that are lined by cu-
boidal clear cells consistent with the diagnosis of PCE (Fig. 2). The
frozen section obtained in the OR (Fig. 3) shows proliferation of
glandular like structures and a vague mucocystic appearance, which led
to the intraoperative diagnosis of yolk sac tumor. On further inspection
of the same image, the papillary projections are seen in the cysts. Im-
munostaining for CK7 was strongly positive (Fig. 4), and negative for
CK20, CD10 and AFP (Fig. 5) consistent with ﬁnal diagnosis of clear cell
papillary cystadenoma of the epididymis.
Fig. 1. Gross pathology of specimen showing the cys8c mass (arrow) and normal tes8cle
just above (double headed arrow).
Fig. 2. H&E stain of Papillary cystadenoma of the epididymis. Epididymal duct with
papillary neoplasm lined by cuboidal lear cells consistent with diagnosis. Papillary ar-
chitecture is noted with cuboidal clear cells (1), stroma and (2) papillary protrusions into
the cysts (arrow).
Fig. 3. Frozen section obtained in OR Proliferation of glandular like structures (1) and
vague mucocystic appearance, led to intraoperative diagnosis of yolk sac tumor.
Fig. 4. CK7 stain positive, consistent with diagnosis of papillary cystadenoma of epidi-
dymis.
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4. Discussion
This is the ﬁrst report of a papillary cystadenoma of the epididymis
in a prepubertal male. To date, the youngest reported patient with a
diagnosis of papillary cystadenoma of the epididymis was 16. PCE bears
close resemblance to renal cell carcinoma (RCC) on H&E staining [4]. In
cases in which unilateral PCE is suspected, immunohistochemical stains
for CD10 which is present in RCC but negative in PCE must be per-
formed to rule out metastatic renal cell carcinoma. While VHL should
be ruled out for patients who present with synchronous bilateral pa-
pillary cystadenoma of the epididymis, most experts discourage ex-
tensive testing in a patient presenting with unilateral disease [5].
The Childhood Cancer Survivor Study and International
Neuroblastoma Risk Group have reported an 18 fold increased risk over
matched controls for the development of secondary neoplasms in pa-
tients treated for high-risk neuroblastoma [6]. Leukemias are the most
common of these neoplasms but soft tissue sarcomas, as well as carci-
nomas of the skin, thyroid, lungs and kidneys have been reported.
However, there have been no previous reports of secondary para-
testicular or testicular neoplasms. There have been several reports of
paratesticular neuroblastoma as a site of metastatic disease from neu-
roblastoma. A retrospective review of 24 testicular and paratesticular
tumors in children by Trobs et al. identiﬁed 13 germ cell tumors, 4 sex
cord stromal tumors, 3 cases of paratesticular rhabdomyosarcoma and
three cases of metastasis, one of which was from neuroblastoma [7].
The metachronous occurrence of PCE following the successful
treatment of neuroblastoma may represent wholly unrelated neoplastic
processes or PCE may have arisen as an uncommon sequelae of the
multimodality chemotherapy and radiotherapy that is typically used to
treat high risk neuroblastoma. Interestingly, allelic loss of the VHL gene
on chromosome 3 has been discovered in benign papillary tumors
presenting with VHL and deletions of the same region of the short arm
of chromosome 3 (often in association with deletions of 11q) have been
observed in a subset of aggressive neuroblastoma [8]. Given that PCE
represents characteristic papillary histology, it is possible that this re-
lates to an innate mutational event or a mutational event as a direct
eﬀect from chemoradiation.
5. Conclusion
This is a unique case, of a paratesticular mass with a rare histology-
papillary cystadenoma of the epididymis, which has never been re-
ported in a prepubertal male. Dissemination of this case is important as
it emphasizes the importance of a broad diﬀerential in evaluating
prepubertal males with paratesticular masses. In this particular case,
given this patients' history of stage IV neuroblastoma, it was believed to
represent a metachronous metastatic site. An intraoperative frozen
section showed yolk sac tumor, which is a predominant histology of
testicular masses seen in prepubertal males. This patient then under-
went the standard of care for yolk sac tumor, a radical orchiectomy.
This case emphasizes the importance of increasing awareness of rare
and unique pathological entities that can be seen in an unexpected
patient population.
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Fig. 5. AFP stain negative, consistent with diagnosis. AFP stain is typically positive in
yolk sac tumors.
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